ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

Anthrax Found At Local P.O.

November 2, 2001

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

NCI Advisors Approve Center Grants For Research On Health Disparities.

November 30, 2001

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990